Rescue renal sympathetic denervation in a patient with ventricular electrical storm refractory to endo- and epicardial catheter ablation

Clinical Research in Cardiology

Volumn 104, Issue 1, 2015, Pages 79-84

  Scholz, Eberhard P ^a   Raake, Philip ^a   Thomas, Dierk ^a   Vogel, Britta ^a   Katus, Hugo A ^a   Blessing, Erwin ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTION POTENTIAL; CASE REPORT; CATHETER ABLATION; ELECTROCARDIOGRAPHY; HEART FUNCTION TEST; HUMAN; INNERVATION; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; RECURRENT DISEASE; SYMPATHECTOMY; TACHYCARDIA, VENTRICULAR; TIME; TREATMENT FAILURE;

ACTION POTENTIALS; CATHETER ABLATION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; KIDNEY; MIDDLE AGED; RECURRENCE; SYMPATHECTOMY; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT FAILURE;

EID: 84926077999     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-014-0749-4     Document Type: Letter

References (29)

1. Members Writing Committee, Zipes DP, Camm AJ et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for practice guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8:746–837. doi:10.1093/europace/eul108
2. Kowey PR (1996) An overview of antiarrhythmic drug management of electrical storm. Can J Cardiol 12(Suppl B):3B–8B
3. Exner DV, Pinski SL, Wyse DG et al (2001) Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation 103:2066–2071
4. Sesselberg HW, Moss AJ, McNitt S et al (2007) Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. HRTHM 4:1395–1402. doi:10.1016/j.hrthm.2007.07.013
5. Gatzoulis KA, Andrikopoulos GK, Apostolopoulos T et al (2005) Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace 7:184–192. doi:10.1016/j.eupc.2005.01.003
6. Schneider HE, Steinmetz M, Krause U et al (2013) Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome. Clin Res Cardiol 102:33–42. doi:10.1007/s00392-012-0492-7
7. Hayase J, Patel J, Narayan SM, Krummen DE (2013) Percutaneous stellate ganglion block suppressing VT and VF in a patient refractory to VT ablation. J Cardiovasc Electrophysiol 24:926–928. doi:10.1111/jce.12138
8. Patel RA, Priore DL, Szeto WY, Slevin KA (2011) Left stellate ganglion blockade for the management of drug-resistant electrical storm. Pain Med 12:1196–1198. doi:10.1111/j.1526-4637.2011.01167.x
9. Schlaich MP, Sobotka PA, Krum H et al (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361:932–934. doi:10.1056/NEJMc0904179
10. Ukena C, Bauer A, Mahfoud F et al (2012) Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol 101:63–67. doi:10.1007/s00392-011-0365-5
11. Hoffmann BA, Steven D, Willems S, Sydow K (2013) Renal sympathetic denervation as an adjunct to catheter ablation for the treatment of ventricular electrical storm in the setting of acute myocardial infarction. J Cardiovasc Electrophysiol. doi:10.1111/jce.12207
12. Remo BF, Preminger M, Bradfield J et al (2014) Safety and efficacy of renal denervation as a novel treatment of ventricular tachycardia storm in patients with cardiomyopathy. Heart Rhythm 11:541–546. doi:10.1016/j.hrthm.2013.12.038
13. Vogel B, Kirchberger M, Zeier M et al (2014) Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry. Clin Res Cardiol 103:117–124. doi:10.1007/s00392-013-0627-5
14. Sosa E, Scanavacca M, d’Avila A et al (2000) Nonsurgical transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia occurring late after myocardial infarction. J Am Coll Cardiol 35:1442–1449
15. Bhatt DL, Kandzari DE, O’Neill WW et al (2014) A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370:1393–1401. doi:10.1056/NEJMoa1402670
16. Pöss J, Mahfoud F, Ukena C et al (2014) Association of vitamin D status and blood pressure response after renal denervation. Clin Res Cardiol 103:41–47. doi:10.1007/s00392-013-0621-y
17. Thukkani AK, Bhatt DL (2013) Renal denervation therapy for hypertension. Circulation 128:2251–2254. doi:10.1161/CIRCULATIONAHA.113.004660
18. Esler MD, Krum H, Schlaich M et al (2012) Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the symplicity HTN-2 randomized, controlled trial. Circulation 126:2976–2982. doi:10.1161/CIRCULATIONAHA.112.130880
19. Krum H, Schlaich M, Whitbourn R et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373:1275–1281. doi:10.1016/S0140-6736(09)60566-3
20. Schlaich MP, Lambert E, Kaye DM et al (2004) Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43:169–175. doi:10.1161/01.HYP.0000103160.35395.9E
21. DiBona GF, Kopp UC (1997) Neural control of renal function. Physiol Rev 77:75–197
22. Linz D, Wirth K, Ukena C et al (2013) Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs. Heart Rhythm 10:1525–1530. doi:10.1016/j.hrthm.2013.07.015
23. Hoffmann BA, Steven D, Willems S, Sydow K (2013) Renal sympathetic denervation as an adjunct to catheter ablation for the treatment of ventricular electrical storm in the setting of acute myocardial infarction. J Cardiovasc Electrophysiol 24:E21. doi:10.1111/jce.12282
24. Linz D, Mahfoud F, Schotten U et al (2012) Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension 60:172–178. doi:10.1161/HYPERTENSIONAHA.112.191965
25. Linz D, van Hunnik A, Ukena C et al (2014) Renal denervation: effects on atrial electrophysiology and arrhythmias. Clin Res Cardiol. doi:10.1007/s00392-014-0695-1
26. Linz D, Ukena C, Mahfoud F et al (2014) Atrial autonomic innervation: a target for interventional antiarrhythmic therapy? J Am Coll Cardiol 63:215–224. doi:10.1016/j.jacc.2013.09.020
27. Villarreal D, Freeman RH, Johnson RA, Simmons JC (1994) Effects of renal denervation on postprandial sodium excretion in experimental heart failure. Am J Physiol 266:R1599–R1604
28. Villarreal D, Freeman RH, Johnson RA (1993) Neurohumoral modulators and sodium balance in experimental heart failure. Am J Physiol 264:H1187–H1193
29. Nozawa T, Igawa A, Fujii N et al (2002) Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats. Heart Vessels 16:51–56